Recently, China NIFDC issued two technical guidelines for hair perming cosmetics. CIRS Group provides an in-depth interpretation covering nine core aspects-offering comprehensive and professional technical support and practical guidance for cosmetics enterprises. Additionally, a detailed comparison between the official versions and the drafts for comments of both guidelines is attached, helping enterprises quickly grasp the key revisions and accurately adapt to the new regulatory requirements.
On April 15, 2026, China’s NIFDC published two trial technical guidelines for hair dye cosmetics, clarifying their scope of application and core requirements for research and quality control. CIRS Group provides a comprehensive interpretation of the key points of both guidelines to help cosmetic enterprises quickly capture compliance essentials and accurately grasp core requirements.
On April 24, 2026, China's National Medical Products Administration (NMPA) issued the Notice on Issuing the 2026 Cosmetics Standard Project Initiation Plan. The plan includes a total of 27 standards related to the cosmetics sector, among which Determination Method for Water Resistance of Sunscreen Cosmetics is a revised standard, and all the rest are newly formulated standards.
On April 13, 2026, China’s National Medical Products Administration (NMPA) carried out the fourth dynamic adjustment to the Inventory of Existing Cosmetic Ingredients in China, involving a total of 50 records. For certain ingredients revised in IECIC I, the updated names differ from those currently listed in the EU Cosmetic Ingredient Catalogue ((EU) 2025/1175) and the US INCI database.
On April 15, 2026, the National Institutes for Food and Drug Control (NIFDC) published six technical guidelines regaeding hair dye, perm and sunscreen cosmetics. The promulgation and implementation of the above technical guidelines provide normative technical basis for the study and quality control of above three kinds of cosmetics.
Based on data retrieved from China’s National Medical Products Administration (NMPA), twelve new cosmetic ingredients have been filed between April 1 and April 13, 2026. Detailed information is provided in the table below. At present, the associated technical specifications have not been made public, and the ingredient has not yet entered the post-filing monitoring period. As of now in 2026, a total of 63 new cosmetic ingredients have been filed.
In June 2025, China’s National Medical Products Administration (NMPA) established a dynamic adjustment mechanism for the "Inventory of Existing Cosmetic Ingredients in China" (hereinafter referred to as the "Inventory"), dividing it into List I and List II for management. On April 13, 2026, the NMPA conducted the fourth dynamic adjustment of the "Inventory," resulting in a total of 50 adjustment records. To date, the "Inventory" has undergone four dynamic adjustments. The following content provides a detailed review of these four adjustments, aiming to help enterprises better understand and comply with the latest cosmetic ingredient regulatory requirements.
To help stakeholders stay informed of the latest developments and gain insights into market trends, this article provides a systematic review and in-depth analysis of the cosmetic ingredient filings published by China’s National Medical Products Administration (NMPA) in March 2026. The report mainly covers the number of new ingredient filings during the month, basic information about the filing enterprises, the regional distribution of domestic filers, ingredients that have been filed multiple times, and interpretations of selected ingredients. It aims to offer valuable data support and information references for the cosmetics industry.
In March 2026, the Shanghai Municipal, Fujian Provincial, Hubei Provincial, and Anhui Provincial Medical Products Administrations successively issued announcements regarding cosmetic supervision and sampling inspections. A total of 12 batches of products were found to be non-compliant. This summary of the announcements aims to help enterprises stay informed of evolving regulatory trends and strengthen their quality management and compliance awareness.
On March 31, 2026, China’s National Medical Products Administration (NMPA) issued the Announcement on Matters Related to Cosmetic Registration and Filing (Draft for Comments) and is now soliciting public comments.
